Scientific review demonstrates multi-target pharmacological mechanisms of Majoon Jograj Guggul in chronic inflammation and neuropathy, highlighting its role in modern clinical integration.
Majoon Jograj Guggul is a renowned polyherbal preparation of the Unani system that has traditionally been prescribed for a variety of musculoskeletal disorders, neurological conditions, and long-standing inflammatory diseases. Classical Unani scholars have described the formulation as possessing Muhallil-e-Waram (anti-inflammatory), Musakkin-e-Alam (pain-relieving), Muqawwi-e-Asab (nervine strengthening), and Muqawwi-e-Mafasil (joint-supportive) properties The formulation is centered on Guggul (Commiphora mukul) and is supplemented with several medicinal plant ingredients that act collectively to enhance its therapeutic effectiveness. Scientific investigations conducted in recent years have provided evidence supporting many of its traditional claims. Research indicates that the bioactive compounds present in the formulation, particularly guggulsterones, flavonoids, terpenoids, and various phenolic constituents, contribute to a broad spectrum of pharmacological effects, including anti-inflammatory, antioxidant, anti-arthritic, neuroprotective, immunomodulatory, and lipid-lowering activities. The present review explores the traditional therapeutic significance, phytochemical composition, and pharmacological potential of Majoon Jograj Guggul while examining the scientific evidence behind its emerging clinical applications. By bridging classical Unani principles with contemporary biomedical research, this review underscores the value of scientifically validating traditional formulations and highlights their potential role in modern healthcare and future therapeutic research.
No takes yet. Share an insight, caveat, or question.
Nomani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: